Primary Open-angle Glaucoma
Showing NaN - NaN of 4
Primary Open-angle Glaucoma, Cataract Trial in United States (CyPass Micro-Stent implanted with CyPass 241-S applier)
Terminated
- Primary Open-angle Glaucoma
- Cataract
- CyPass Micro-Stent implanted with CyPass 241-S applier
- Cataract surgery
-
Phoenix, Arizona
- +19 more
Aug 24, 2022
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- PF-04217329 - Lowest Dose
- +8 more
-
Artesia, California
- +22 more
Apr 6, 2021
Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (LX7101 (0.125%), LX7101 (0.25%), LX7101 Vehicle)
Completed
- Primary Open-angle Glaucoma
- Ocular Hypertension
- LX7101 (0.125%)
- +2 more
-
Morrow, Georgia
- +4 more
Aug 31, 2015
Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (OPA-6566, Placebo, Latanoprost)
Completed
- Primary Open-angle Glaucoma
- Ocular Hypertension
- OPA-6566
- +2 more
-
Artesia, California
- +8 more
Feb 7, 2014